Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the https://saadiyas511910.wikihearsay.com/4003903/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment